Skip to main content
Terug
Watch Compare

KORU Medical Systems, Inc.

Datakwaliteit: 100%
KRMD
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 4,34
▲ € 0,15 (3,58%)
Marktkapitalisatie: 201,25 M
Prijs
€ 4,34
Marktkapitalisatie
201,25 M
Dagbereik
€ 4,00 — € 4,39
52-Weeksbereik
€ 2,08 — € 6,61
Volume
722.902
Openen € 4,20
50D / 200D Gem.
€ 4,72
8,05% below
50D / 200D Gem.
€ 4,47
2,94% below

Quick Summary

Belangrijkste Punten

Revenue grew 15,03% annually over 5 years — strong growth
Generating 462.405,0 in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,20%

Groei

Revenue Growth (5Y)
15,03%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)22,23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-15,99%
Boven sectorgemiddelde (-53,41%)
ROIC-12,12%
Net Margin-6,41%
Op. Margin-7,23%

Veiligheid

Debt / Equity
N/A
Current Ratio2,48
Interest CoverageN/A

Waardering

PE (TTM)
-76,29
Onder sectorgemiddelde (-1,48)
P/B Ratio12,22
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -76,3 -1,5
P/B 12,2 1,6
ROE % -16,0 -53,4
Net Margin % -6,4 -41,5
Rev Growth 5Y % 15,0 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 22,23% Revenue Growth (3Y) 20,09%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15,03% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 41,13 M Net Income (TTM) -2,64 M
ROE -15,99% ROA -10,03%
Gross Margin 62,26% Operating Margin -7,23%
Net Margin -6,41% Free Cash Flow (TTM) 462.405,0
ROIC -12,12% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,48
Interest Coverage N/A Asset Turnover 1,56
Working Capital 11,59 M Tangible Book Value 15,78 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -76,29 Forward P/E N/A
P/B Ratio 12,22 P/S Ratio 4,89
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0,23%
Market Cap 201,25 M Enterprise Value 192,78 M
Per Share
EPS (Diluted TTM) -0,06 Revenue / Share 0,89
FCF / Share 0,01 OCF / Share 0,01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -17,53%
SBC-Adj. FCF -1,89 M Growth Momentum 7,20

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 41,13 M 33,65 M 28,52 M 27,90 M 23,49 M
Net Income -2,64 M -6,07 M -13,74 M -8,66 M -4,56 M
EPS (Diluted) -0,06 -0,13 -0,30 -0,19 -0,10
Gross Profit 25,60 M 21,33 M 16,71 M 15,37 M 13,77 M
Operating Income -2,97 M -6,45 M -10,27 M -10,78 M -7,03 M
EBITDA — — — — —
R&D Expenses 4,39 M 5,26 M 5,74 M 4,96 M 2,47 M
SG&A Expenses 23,38 M 21,63 M 20,37 M 20,61 M 17,86 M
D&A 810.500,0 888.473,0 870.390,0 587.137,0 463.130,0
Interest Expense — — — — —
Income Tax 21.890,0 2.893,0 3,97 M -2,01 M 1,80 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 28,20 M 27,22 M 28,46 M 42,33 M 41,29 M
Total Liabilities 11,15 M 10,40 M 8,11 M 11,01 M 4,79 M
Shareholders' Equity 17,05 M 16,81 M 20,35 M 31,33 M 36,50 M
Total Debt — — — — —
Cash & Equivalents 8,87 M 9,58 M 11,48 M 17,41 M 25,33 M
Current Assets 19,99 M 19,13 M 20,26 M 29,80 M 37,32 M
Current Liabilities 8,19 M 7,20 M 4,45 M 6,96 M 4,79 M